Rab36 activators encompass a diverse set of chemicals that can indirectly modulate the activity or functionality of Rab36 through various signaling pathways and cellular processes. For instance, compounds like Forskolin and PMA operate by influencing intracellular signaling cascades, such as cAMP and PKC pathways, which intersect with vesicle trafficking and potentially the role of Rab36 therein. This highlights the extensive network of signaling pathways that can be intertwined with Rab36's function in vesicular transport.
The overarching theme with Rab36 activators, as evidenced by compounds like U0126, MG132, and the PI3K inhibitors Wortmannin and LY294002, is their potential to modify vesicle trafficking either directly or through a cascade of cellular signals. The influence on vesicle trafficking pathways becomes more evident when considering agents like Nocodazole and Brefeldin A, which act directly on cellular organelles or cytoskeletal elements involved in vesicle movement. Additionally, the involvement of Ras signaling, through agents like Manumycin A and FTS, further indicates the intricate interplay between various cellular signaling pathways and Rab36's role in vesicle trafficking.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates cAMP levels which can influence various cellular processes and may indirectly affect Rab GTPase activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), potentially influencing GTPase activity and vesicle trafficking involving Rab36. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor which might indirectly affect Rab GTPase turnover and function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor; given the role of PI3K in vesicle trafficking, it may indirectly influence Rab36 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor; can modulate vesicle trafficking pathways, potentially affecting Rab36. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
By inhibiting protein phosphatases, it may affect phosphorylation status of proteins involved in Rab36-mediated pathways. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
A Ras farnesyltransferase inhibitor; by affecting Ras, it might indirectly modulate Rab36's function. | ||||||
Farnesyl thiosalicylic acid | 162520-00-5 | sc-205322 sc-205322A | 1 mg 5 mg | $61.00 $82.00 | 15 | |
Dislodges Ras from membranes; its effect on Ras might lead to indirect modulation of Rab36 activity. | ||||||